Bingchuan Wei
Senior Principal Scientist, CMC Team Lead Genentech
Bingchuan Wei is a senior principal scientist from Genentech Inc, a member of Roche Group. He is a scientific leader with 15 years of experience in the analytical and CMC development of different therapeutic modalities, including small molecules, oligonucleotides, peptides, monoclonal antibodies, antibody-drug conjugates and cell therapies. His research centers on developing and leveraging advanced analytical technologies in drug development, understanding the structural-functional relationship of therapeutics, and fostering entrepreneurial spirit in the biopharmaceutical industry. Bingchuan has published over 40 peer-reviewed journal publications and over 40 oral presentations. Bingchuan holds Ph.D. in Analytical Chemistry from Purdue University, M.B.A. from The Pennsylvania State University and B.S. in chemistry and mathematics from Peking University.
Seminars
- Highlighting the necessity to leverage high throughput methods and automation to accelerate ADC process and analytical characterization
- Laying out methodology is incorporate automation in PAT and increases platform throughput in ADC development
- Understanding high throughput methods for process monitoring and real time bioconjugation approaches
